Cogstate Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Cogstate Stock Forecast and Price Target
Cogstate has an average price target of $1.80 recently offered by notable experts for 2024, which would represent a potential upside of approximately 31.39% from the last closing price in April, 2024 if reached. This potential increase is based on a high estimate of $1.80 and a low estimate of $1.80. If you're thinking of investing in CGS stock, it might be good to look at its rivals too.
31.39% Upside
Cogstate Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Cogstate's Price has decreased by 100.00%, from $0.20 to $0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach $0.10 – an increase of 100.00%. The Cogstate forecast is for Fair Value to reach $0.11 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CSL Stock Forecast | CSL | Outperform |
12
|
$273.30 | Buy/Sell | $205.51 | -25.66% |
| TLX Stock Forecast | Telix Pharmaceuticals | Buy |
6
|
$14.91 | Buy/Sell | $13.37 | -2.75% |
| NEU Stock Forecast | Neuren Pharmaceuticals | Buy |
11
|
$18.65 | Buy/Sell | $26.43 | 42.52% |
| PNV Stock Forecast | PolyNovo | Outperform |
8
|
$1.99 | Buy/Sell | $1.88 | 7.54% |
| IMU Stock Forecast | Imugene | Buy |
4
|
$0.08 | Buy/Sell | $0.35 | 425.00% |
Cogstate Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Cogstate's Revenue has increased by 70.75%, going from $23.69M to $40.45M. For the next year, 0 analysts project Cogstate's Revenue to drop by 14.54%, reaching $34.57M. By 2030, professionals believe that Cogstate's Revenue will decrease by 8.48%, reaching $37.02M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CUV Stock Forecast | Clinuvel Pharmaceuticals | Buy |
16
|
$14.57 | Buy/Sell | $27.41 | 52.71% |
| OPT Stock Forecast | Opthea | Underperform |
10
|
$0.63 | Buy/Sell | $1.15 | -44.44% |
| IMM Stock Forecast | Immutep | Buy |
8
|
$0.42 | Buy/Sell | $1.26 | 138.10% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MSB Stock Forecast | Mesoblast | Buy |
9
|
$0.93 | Buy/Sell | $0.69 | 18.28% |
| PYC Stock Forecast | PYC Therapeutics | Buy |
8
|
$0.09 | Buy/Sell | $0.30 | 288.89% |
| BOT Stock Forecast | Botanix Pharmaceuticals | - |
0
|
$0.19 | Buy/Sell | $0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DXB Stock Forecast | Dimerix |
0
|
$0.32 | Buy/Sell | $0.00 | 81.25% | |
| ACW Stock Forecast | Actinogen Medical |
5
|
$0.03 | Buy/Sell | $0.15 | -100.00% | |
| BIT Stock Forecast | Biotron | - |
0
|
$0.06 | Buy/Sell | $0.00 | -100.00% |
Cogstate EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Cogstate's EBITDA has grown, increasing from $-1.05M to $2.67M – a growth of 354.29%. The next year looks promising for Cogstate, with analysts predicting EBITDA of $13.37M – an increase of 400.75%. Over the next seven years, experts anticipate that Cogstate's EBITDA will grow at a rate of 728.59%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SPL Stock Forecast | Starpharma Holdings | - |
8
|
$0.14 | Buy/Sell | $0.95 | -100.00% |
| IVX Stock Forecast | Invion | - |
0
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| PTX Stock Forecast | Prescient Therapeutics |
2
|
$0.05 | Buy/Sell | $0.20 | 180.00% |
Cogstate EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Cogstate's EBIT has grown by 242.24%, from $-1.61M to $2.29M. For the next year, analysts are expecting EBIT to reach $9.28M – an increase of 305.24%. Over the next seven years, experts predict that EBIT will grow by 714.29%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CYP Stock Forecast | Cynata Therapeutics |
0
|
$0.21 | Buy/Sell | $1.24 | 490.48% | |
| 1AI Stock Forecast | Algorae Pharmaceuticals | - |
-4
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| IMC Stock Forecast | Immuron | - |
0
|
$0.07 | Buy/Sell | $0.00 | -100.00% |
Cogstate EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Cogstate's EPS has decreased by 100.00%, from $0.06 to $0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach $0.03 – an increase of 100.00%. The Cogstate forecast is for EPS to reach $0.03 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATH Stock Forecast | Alterity Therapeutics | - |
0
|
$0.00 | Buy/Sell | $0.75 | 0.00% |
| GTG Stock Forecast | Genetic Technologies |
0
|
$0.12 | Buy/Sell | $1.00 | -50.00% | |
| OSL Stock Forecast | OncoSil Medical | - |
0
|
$0.01 | Buy/Sell | $0.11 | -100.00% |
.jpg)